Skip to main content
Premium Trial:

Request an Annual Quote

CompanionDx Taps GenomOncology to Support NGS-based Cancer Asssays

Premium

NEW YORK (GenomeWeb) – GenomOncology said this week that CompanionDX, a CLIA-certified laboratory that specializes in pharmacogenomics, cancer companion diagnostics, and targeted next-generation sequencing, will use its solution to support its suite of next-generation sequencing-based cancer assays.

GenomOncology’s GO Clincal Workbench will help researchers in CompanionDx’s lab "manage increased volume and quickly add new assays to meet the needs of our oncologists" as well as create and deliver "therapy-driven clinical reports," David Lasecki, CompanionDx’s president said in a statement.

Financial and other terms of the agreement were not disclosed.

Last week, GenomOncology said that Cleveland's University Hospitals will use the GO Clinical Workbench to launch its first next-generation sequencing-based cancer diagnostic test.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.